Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 24% ± 9% | |
| microglial cell | 5 studies | 23% ± 6% | |
| cardiac muscle cell | 4 studies | 20% ± 2% | |
| adipocyte | 4 studies | 20% ± 2% | |
| astrocyte | 4 studies | 32% ± 15% | |
| oligodendrocyte precursor cell | 4 studies | 24% ± 10% | |
| endothelial cell of lymphatic vessel | 4 studies | 19% ± 0% | |
| macrophage | 4 studies | 29% ± 7% | |
| GABAergic neuron | 3 studies | 38% ± 13% | |
| interneuron | 3 studies | 44% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 35% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 459.29 | 1444 / 1445 | 100% | 6.88 | 183 / 183 |
| stomach | 100% | 390.54 | 359 / 359 | 99% | 8.34 | 283 / 286 |
| intestine | 100% | 533.14 | 965 / 966 | 99% | 7.66 | 522 / 527 |
| ovary | 100% | 547.66 | 180 / 180 | 98% | 7.84 | 422 / 430 |
| kidney | 100% | 488.27 | 89 / 89 | 97% | 7.31 | 875 / 901 |
| brain | 98% | 283.05 | 2586 / 2642 | 99% | 7.12 | 698 / 705 |
| breast | 100% | 545.49 | 459 / 459 | 97% | 6.81 | 1083 / 1118 |
| thymus | 100% | 479.73 | 653 / 653 | 97% | 5.74 | 586 / 605 |
| pancreas | 99% | 240.69 | 325 / 328 | 97% | 4.89 | 173 / 178 |
| skin | 100% | 435.38 | 1807 / 1809 | 95% | 6.44 | 450 / 472 |
| uterus | 100% | 500.95 | 170 / 170 | 94% | 6.02 | 432 / 459 |
| bladder | 100% | 444.33 | 21 / 21 | 94% | 5.92 | 473 / 504 |
| liver | 100% | 318.08 | 225 / 226 | 93% | 4.75 | 378 / 406 |
| adrenal gland | 100% | 649.04 | 258 / 258 | 90% | 5.04 | 206 / 230 |
| lung | 100% | 378.75 | 577 / 578 | 85% | 4.96 | 979 / 1155 |
| prostate | 100% | 325.49 | 244 / 245 | 28% | 0.81 | 139 / 502 |
| adipose | 100% | 536.44 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 543.22 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 863.21 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 441.76 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 633.72 | 923 / 929 | 0% | 0 | 0 / 0 |
| heart | 96% | 612.11 | 830 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 5.65 | 43 / 45 |
| eye | 0% | 0 | 0 / 0 | 95% | 4.68 | 76 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 4.50 | 27 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045329 | Biological process | carnitine biosynthetic process |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0050353 | Molecular function | trimethyllysine dioxygenase activity |
| Gene name | TMLHE |
| Protein name | Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD) |
| Synonyms | TMLH |
| Description | FUNCTION: Converts trimethyllysine (TML) into hydroxytrimethyllysine (HTML) . . |
| Accessions | ENST00000334398.8 [Q9NVH6-1] ENST00000675642.1 [Q9NVH6-8] ENST00000369439.4 [Q9NVH6-2] Q9NVH6 |
